GO:0007186 G protein-coupled receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007186 describes the molecular process in which a ligand-bound G protein-coupled receptor (GPCR) activates a heterotrimeric G protein by promoting GDP-to-GTP exchange on the G-alpha subunit.
• GPCR signaling is one of the most versatile transduction systems in eukaryotes and can begin at the plasma membrane, Golgi or nuclear membrane.
• Arrestins terminate canonical G protein signaling and initiate independent signaling waves, a phenomenon known as biased signaling.
• GPCRs control neurological disease, inflammation, metabolism, gametogenesis and retinal phototransduction, making them high-value drug targets.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of GPCR pathway genes in disease-relevant cells.
• EDITGENE provides end-to-end CRISPR cell model and library screening services for GPCR pathway research.
Description
G protein-coupled receptor signaling pathway (GO:0007186) is the biological process that begins when an extracellular or intracellular ligand binds a G protein-coupled receptor (GPCR) and ends with regulation of a downstream cellular process. The activated receptor acts as a guanine nucleotide exchange factor for the alpha-subunit of an associated heterotrimeric G protein, promoting exchange of GDP for GTP. The GTP-bound G-alpha subunit then dissociates from the beta- and gamma-subunits and transmits the signal to effector proteins. This pathway can initiate from the plasma membrane, Golgi or nuclear membrane, reflecting the broad subcellular distribution of GPCRs. Researchers study GO:0007186 because it is central to physiology and disease, from neurological disorders and inflammation to hypercholesterolemia and retinal degeneration. The pathway is also a dominant source of drug targets, and biased allosteric modulators are being developed to selectively tune specific arms of GPCR signaling. Understanding the molecular steps, regulatory checkpoints and disease links of GO:0007186 is therefore essential for both basic and translational research.
G protein-coupled receptor signaling pathway At A Glance
| GO ID | GO:0007186 |
|---|---|
| GO term | G protein-coupled receptor signaling pathway |
| Ontology | biological_process |
| Synonym | GPCR signaling pathway; GPCR signalling pathway; G-protein coupled receptor protein signaling pathway; G-protein coupled receptor protein signal transduction; G-protein coupled receptor signaling pathway via GPCR dimer |
| Major function | Ligand-induced activation of heterotrimeric G proteins and downstream cellular regulation |
| Subcellular initiation sites | Plasma membrane, Golgi or nuclear membrane |
| Key molecular event | GDP-to-GTP exchange on the G-alpha subunit |
| Major regulators | Arrestins, G protein-coupled receptor kinases, allosteric modulators |
| Disease relevance | Neurological disease, inflammation, hypercholesterolemia, atherosclerosis, retinal degeneration |
What Is GO:0007186?
GO:0007186 is defined as the series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction and ends with regulation of a downstream cellular process, and it can start from the plasma membrane, Golgi or nuclear membrane.
Why Is G protein-coupled receptor signaling pathway Important in Cell Biology?
GO:0007186 is important because GPCR signaling is one of the largest and most therapeutically exploited signal transduction systems in human biology, controlling processes as diverse as neurotransmission, immune cell recruitment, lipid metabolism, gametogenesis and vision. Dysregulation of this pathway contributes to neurological disease, chronic inflammation, atherosclerosis and retinal degeneration, and many current drugs target GPCRs or their downstream effectors.
• GPCR signaling regulates neurotransmission and is implicated in neurological disease mechanisms.
• Arrestin recruitment and heteromer formation diversify GPCR signaling outputs and drug responses.
• GPCR pathways control gametogenesis via PKG-mediated signaling cascades in model organisms.
• Biased allosteric modulators are an emerging frontier in GPCR drug discovery.
• GPR146 deficiency protects against hypercholesterolemia and atherosclerosis, linking GPCR signaling to lipid metabolism.
• Receptor tyrosine kinase and GPCR crosstalk modulates synaptic plasticity.
• GPCR signaling is essential for retinal rod outer segment function and phototransduction.
• GPR84 regulates acute inflammation in normal and diabetic skin wounds.
• GPCRs are highly druggable and remain a major target class for small-molecule and biologic therapeutics.
• CRISPR-based models enable causal dissection of GPCR pathway genes in disease-relevant cells.
What Happens During G protein-coupled receptor signaling pathway?
Ligand binding and receptor activation
In simple terms: A signal molecule docks onto a GPCR, switching the receptor into its active shape.
The pathway begins when a ligand binds to a GPCR, stabilizing an active receptor conformation that can engage a heterotrimeric G protein. This receptor-ligand interaction is the initiating step of GO:0007186 and can occur at the plasma membrane, Golgi or nuclear membrane. Structural studies of retinal rod outer segment GPCR signaling have revealed how receptor activation propagates conformational changes to the G protein.
GDP-to-GTP exchange on G-alpha
In simple terms: The activated receptor acts like a switch that swaps a spent GDP molecule for a fresh GTP on the G protein.
The activated receptor promotes exchange of GDP for GTP on the alpha-subunit of the associated heterotrimeric G-protein complex. This guanine nucleotide exchange event is the defining molecular step of GO:0007186 and converts the G-alpha subunit into its active, GTP-bound state.
G-alpha dissociation and effector regulation
In simple terms: The energized G protein splits apart so its pieces can pass the message to other proteins inside the cell.
The GTP-bound activated alpha-G-protein dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. These liberated subunits regulate downstream effectors, ultimately ending with regulation of a downstream cellular process as specified in the GO:0007186 definition.
Arrestin recruitment and biased signaling
In simple terms: Another protein called arrestin can bind the receptor, shut down one wave of signaling and start a different one.
Arrestin recruitment and signaling by GPCR heteromers represent an important layer of GO:0007186 regulation, terminating canonical G protein signaling while initiating arrestin-dependent signals. Biased allosteric modulators exploit this complexity to selectively activate or block specific GPCR signaling arms, which is a new frontier in GPCR drug discovery.
Crosstalk with receptor tyrosine kinases
In simple terms: GPCRs can talk to other receptor systems, such as receptor tyrosine kinases, to fine-tune synaptic signals.
Synaptic plasticity can be modulated via receptor tyrosine kinase and GPCR crosstalk, showing that GO:0007186 does not operate in isolation but integrates with other signaling networks. This crosstalk expands the regulatory repertoire of GPCR signaling in neurons and other cell types.
Key Genes Involved in GO:0007186 G protein-coupled receptor signaling pathway
The following genes and proteins are central to G protein-coupled receptor signaling pathway (GO:0007186) research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPR39 | G protein-coupled receptor 39 | Implicated in neurological disease signaling mechanisms |
| GPR146 | G protein-coupled receptor 146 | Deficiency protects against hypercholesterolemia and atherosclerosis |
| GPR84 | G protein-coupled receptor 84 | Regulates acute inflammation in normal and diabetic skin wounds |
| ADRB2 | Beta-2 adrenergic receptor | Prototypical GPCR for biased signaling and arrestin studies |
| AGTR1 | Angiotensin II receptor type 1 | Model GPCR for heteromer and arrestin recruitment studies |
| DRD2 | Dopamine receptor D2 | GPCR relevant to neurological and psychiatric disease research |
| OPRM1 | Mu opioid receptor | GPCR target for biased allosteric modulator development |
| CXCR4 | C-X-C chemokine receptor type 4 | GPCR involved in inflammation and cell migration |
| RHO | Rhodopsin | Light-activated GPCR essential for retinal rod outer segment signaling |
| GNAS | G-alpha s subunit | Mediates GDP-to-GTP exchange downstream of GPCRs |
| GNAI1 | G-alpha i subunit | Inhibitory G protein alpha subunit in GPCR signaling |
| GNAQ | G-alpha q subunit | Activates phospholipase C downstream of GPCRs |
| GNB1 | G protein beta subunit 1 | Forms heterotrimer with G-alpha and G-gamma |
| GNG2 | G protein gamma subunit 2 | Part of the heterotrimeric G protein complex |
| ARRB1 | Beta-arrestin 1 | Terminates G protein signaling and initiates arrestin signaling |
| ARRB2 | Beta-arrestin 2 | Regulates GPCR desensitization and biased signaling |
| GRK2 | G protein-coupled receptor kinase 2 | Phosphorylates activated GPCRs to promote arrestin binding |
How Is G protein-coupled receptor signaling pathway Regulated?
GO:0007186 is regulated at multiple levels. G protein-coupled receptor kinases phosphorylate activated receptors to promote arrestin binding, which desensitizes G protein signaling and can initiate arrestin-dependent signals. Biased allosteric modulators can selectively enhance or suppress specific signaling arms, providing pharmacological control of the pathway. Crosstalk with receptor tyrosine kinases adds another layer of regulation, as shown for synaptic plasticity. In addition, GPCR heteromer formation can alter arrestin recruitment and downstream signaling compared with homomeric receptors.
G protein-coupled receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR39 | Neurological disease | Knockout neuronal cell line |
| GPR146 | Hypercholesterolemia and atherosclerosis | Knockout hepatocyte or macrophage model |
| GPR84 | Acute inflammation in diabetic skin wounds | Knockout macrophage or keratinocyte model |
| RHO | Retinal degeneration and phototransduction defects | Knock-in rhodopsin mutant in retinal cells |
| ARRB2 | Biased signaling and drug response | Point-mutation knock-in of arrestin phospho-sites |
Neurological disease
GPR39-mediated signaling mechanisms contribute to neurological diseases, linking GO:0007186 to neuronal dysfunction. GPCR signaling crosstalk with receptor tyrosine kinases regulates synaptic plasticity, a process central to learning and memory.
Metabolic and cardiovascular disease
GPR146 deficiency protects against hypercholesterolemia and atherosclerosis, demonstrating that GPCR signaling directly influences lipid metabolism and cardiovascular risk. This makes GO:0007186 a relevant pathway for metabolic disease research.
Inflammation and wound healing
GPR84 regulates acute inflammation in normal and diabetic skin wounds, connecting GPCR signaling to innate immune responses and tissue repair. Chemokine receptors such as CXCR4 also participate in inflammatory cell recruitment.
Retinal degeneration
Structural studies of GPCR signaling in the retinal rod outer segment have clarified how rhodopsin activation and G protein coupling support phototransduction, with implications for retinal disease.
From G protein-coupled receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a GPCR alter downstream signaling? | CRISPR knockout cell line |
| Does a specific GPCR mutation change ligand response? | CRISPR point-mutation knock-in |
| Can a tagged GPCR be tracked in live cells? | Tagged knock-in of fluorescent or epitope tag |
| Does GPCR overexpression drive disease phenotypes? | CRISPR overexpression cell model |
| Which GPCR pathway genes are essential in a disease context? | CRISPR library screening |
| How does arrestin recruitment change with heteromerization? | Knock-in arrestin reporter cell line |
How to Study the G protein-coupled receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Testing GPCR gene necessity |
| CRISPR point mutation | Effect of specific residue change | Dissecting ligand binding or phosphorylation sites |
| Knock-in reporter | Real-time signaling dynamics | Tracking arrestin recruitment or G protein activation |
| Overexpression | Gain-of-function phenotype | Modeling GPCR-driven disease states |
| CRISPR library screening | Genome-wide essentiality | Identifying GPCR pathway dependencies |
| Structural biology | Receptor-G protein interface | Understanding activation mechanisms |
| Live-cell imaging | Subcellular signaling location | Detecting plasma membrane, Golgi or nuclear signaling |
| Bioinformatics pathway analysis | Pathway enrichment and networks | Prioritizing GPCR candidates from omics data |
CRISPR knockout and point-mutation models
CRISPR knockout of GPCR genes such as GPR146 and GPR84 has been used to test causal roles in hypercholesterolemia and inflammation, respectively. Point-mutation knock-in can dissect specific phosphorylation or ligand-binding residues that control biased signaling.
Signaling assays and arrestin recruitment
Arrestin recruitment assays are widely used to measure GPCR desensitization and biased signaling, including in heteromer studies. These assays complement G protein activation measurements to provide a complete picture of GO:0007186 activity.
Structural and imaging approaches
Structural studies of retinal rod outer segment GPCR signaling have provided high-resolution views of receptor-G protein coupling. Live-cell imaging of tagged GPCRs and G proteins can reveal subcellular sites of signaling initiation, including plasma membrane, Golgi and nuclear membrane.
Library screening and bioinformatics
CRISPR library screening enables unbiased identification of GPCR pathway genes required for a phenotype, such as inflammation or drug response. Bioinformatics integration of screening data with pathway databases helps prioritize candidate GPCRs and effectors for follow-up.
How CRISPR Can Be Used to Study GO:0007186 G protein-coupled receptor signaling pathway
Knockout
CRISPR knockout of GPCR genes such as GPR146 and GPR84 has been used to demonstrate causal roles in hypercholesterolemia and acute inflammation. Knockout models are ideal for testing whether a GPCR is required for a specific signaling output within GO:0007186.
Point Mutation
Point-mutation knock-in can alter specific residues in GPCRs or arrestins to test their role in biased signaling and desensitization. This approach is valuable for separating G protein-dependent from arrestin-dependent arms of GO:0007186.
Knock-in
Knock-in of fluorescent or epitope tags allows tracking of GPCR localization and trafficking at the plasma membrane, Golgi or nuclear membrane. Tagged knock-in models are also useful for structural and imaging studies of receptor-G protein coupling.
Overexpression
CRISPR-mediated overexpression of GPCRs or G protein subunits can model gain-of-function disease states and amplify signaling for biochemical assays. Overexpression models are particularly useful when endogenous receptor levels are low.
How EDITGENE Supports G protein-coupled receptor signaling pathway Research
Researchers studying G protein-coupled receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in a disease phenotype or drug response. EDITGENE provides publication-ready CRISPR cell models and screening services to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for G protein-coupled receptor signaling pathway research.
Frequently Asked Questions About G protein-coupled receptor signaling pathway
What is GO:0007186?
GO:0007186 is the Gene Ontology term for G protein-coupled receptor signaling pathway, the process in which a ligand-bound GPCR activates a heterotrimeric G protein by promoting GDP-to-GTP exchange on the G-alpha subunit.
What is the G protein-coupled receptor signaling pathway?
It is a series of molecular signals initiated by ligand binding to a GPCR, leading to G-alpha activation, dissociation from beta-gamma subunits and regulation of downstream cellular processes.
What genes are involved in G protein-coupled receptor signaling pathway?
Key genes include GPR39, GPR146, GPR84, ADRB2, AGTR1, DRD2, OPRM1, CXCR4, RHO, GNAS, GNAI1, GNAQ, GNB1, GNG2, ARRB1, ARRB2 and GRK2.
Where does GPCR signaling start in the cell?
GPCR signaling can start from the plasma membrane, Golgi or nuclear membrane.
How is GPCR signaling terminated?
G protein-coupled receptor kinases phosphorylate activated receptors, promoting arrestin binding, which desensitizes G protein signaling and can initiate arrestin-dependent signals.
What is biased signaling in GPCRs?
Biased signaling is the preferential activation of one GPCR signaling arm, such as G protein versus arrestin, and can be tuned by biased allosteric modulators.
Which diseases are linked to GPCR signaling?
GPCR signaling is linked to neurological disease, hypercholesterolemia, atherosclerosis, inflammation, diabetic wound healing and retinal degeneration.
How do CRISPR models help study GPCR signaling?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of GPCR pathway genes in disease-relevant cells.
What is the role of GPR146 in disease?
GPR146 deficiency protects against hypercholesterolemia and atherosclerosis.
What is the role of GPR84 in inflammation?
GPR84 regulates acute inflammation in normal and diabetic skin wounds.
Conclusion
GO:0007186, the G protein-coupled receptor signaling pathway, is a central biological process that converts ligand binding into diverse cellular responses through heterotrimeric G protein activation and arrestin-mediated regulation. Its involvement in neurological disease, metabolic disorders, inflammation and retinal function makes it a high-priority research and drug discovery area. CRISPR-based knockout, point-mutation, knock-in, overexpression and library screening models provide the causal evidence needed to translate GPCR biology into therapeutic insight.
References
- 1. Cao B et al.. 2023. Signaling pathway mechanisms of neurological diseases induced by G protein-coupled receptor 39.. CNS Neurosci Ther 29(6):1470-1483 PMID: 36942516
- 2. Mores KL et al.. 2019. Arrestin recruitment and signaling by G protein-coupled receptor heteromers.. Neuropharmacology 152:15-21 PMID: 30419245
- 3. Wang PP et al.. 2022. A G-Protein-Coupled Receptor Modulates Gametogenesis via PKG-Mediated Signaling Cascade in Plasmodium berghei.. Microbiol Spectr 10(2):e0015022 PMID: 35404079
- 4. Slosky LM et al.. 2021. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.. Trends Pharmacol Sci 42(4):283-299 PMID: 33581873
- 5. Yu H et al.. 2019. GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis.. Cell 179(6):1276-1288.e14 PMID: 31778654
- 6. Lao-Peregrin C et al.. 2024. Synaptic plasticity via receptor tyrosine kinase/G-protein-coupled receptor crosstalk.. Cell Rep 43(1):113595 PMID: 38117654
- 7. Gulati S et al.. 2023. Structural view of G protein-coupled receptor signaling in the retinal rod outer segment.. Trends Biochem Sci 48(2):172-186 PMID: 36163145
- 8. Cooper PO et al.. 2024. G-protein-coupled receptor 84 regulates acute inflammation in normal and diabetic skin wounds.. Cell Rep 43(6):114288 PMID: 38814782
